Mice subsequently treated with Abatacept and IgG-(IL-2) 2 showed a trend towards retention of more functional beta cell mass as judged by glucose tolerance tests (Supplementary Fig. 8 ).
← all excerpts
Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity.
1
—
—